abiraterone has been researched along with Acute Kidney Failure in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Balusson, F; Campillo-Gimenez, B; Despas, F; Happe, A; Kerbrat, S; Mathieu, R; Nowak, E; Oger, E; Scailteux, LM; Vincendeau, S | 1 |
Dineen, M; Guancial, E; Hansen, E; Sahasrabudhe, D; Sievert, L | 1 |
Bhargava, R; Hendricks, AR; Neyra, JA; Rocha, NA; Rodan, AR; Vaidya, OU | 1 |
1 review(s) available for abiraterone and Acute Kidney Failure
Article | Year |
---|---|
Abiraterone-induced rhabdomyolysis resulting in acute kidney injury: A case report and review of the literature.
Topics: Acute Kidney Injury; Aged; Androstenes; Disease Progression; Fatal Outcome; Humans; Male; Prostatic Neoplasms, Castration-Resistant; Rhabdomyolysis | 2018 |
2 other study(ies) available for abiraterone and Acute Kidney Failure
Article | Year |
---|---|
Hospitalization for adverse events under abiraterone or enzalutamide exposure in real-world setting: A French population-based study on prostate cancer patients.
Topics: Acute Kidney Injury; Androstenes; Atrial Fibrillation; Benzamides; Brain Ischemia; Hospitalization; Humans; Male; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Stroke; Treatment Outcome | 2022 |
Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report.
Topics: Acute Kidney Injury; Aged; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Denosumab; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Prostatic Neoplasms, Castration-Resistant; Rhabdomyolysis; Rosuvastatin Calcium | 2015 |